0 — Class II drug recall D-0374-2019
Terminated recall by PharMEDium Services, LLC., reported 2019-01-16, distributed nationwide. Subpotent
| Recall number | D-0374-2019 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | PharMEDium Services, LLC., Cleveland, MS, United States |
| Recall initiated | 2019-01-02 |
| Classified | 2019-01-14 |
| Reported by FDA | 2019-01-16 |
| Terminated | 2020-05-07 |
| Distributed | Nationwide (US) |
| Quantity | 7,711 syringes |
| Reason classes | potency |
Product
0.9% Buffered Lidocaine HCl (buffered in 8.4% Sodium Bicarbonate) a.) 1 mL in 3 mL BD Syringe, 10 per carton, b.) 0.9% Buffered Lidocaine HCl (buffered in 8.4% Sodium Bicarbonate) 5 mL in 5 mL BD Syringe, 10 per carton Rx Only, Compounded by PharMEDium Services, LLC, Sugar Land, TX 77478.
Reason for recall
Subpotent
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0374-2019. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.